These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8595798)

  • 1. Consequences of the Sicilian Gambit.
    Rosen MR
    Eur Heart J; 1995 Aug; 16 Suppl G():32-6. PubMed ID: 8595798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Sicilian gambit. A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology.
    Circulation; 1991 Oct; 84(4):1831-51. PubMed ID: 1717173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 'Sicilian Gambit'. A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. The Task Force of the Working Group on Arrhythmias of the European Society of Cardiology.
    Eur Heart J; 1991 Oct; 12(10):1112-31. PubMed ID: 1723682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Sicilian Gambit revisited--theory and practice.
    Schwartz PJ; Zaza A
    Eur Heart J; 1992 Nov; 13 Suppl F():23-9. PubMed ID: 1478220
    [No Abstract]   [Full Text] [Related]  

  • 5. ["Sicilian gambit": pathophysiological approach to drug therapy of arrhythmia (lecture]].
    Sulimov VA
    Ter Arkh; 1999; 71(8):67-74. PubMed ID: 10515042
    [No Abstract]   [Full Text] [Related]  

  • 6. Can antiarrhythmic agents be selected based on mechanism of action?
    Lau W; Newman D; Dorian P
    Drugs; 2000 Dec; 60(6):1315-28. PubMed ID: 11152014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Putting the Sicilian Gambit to the test.
    Janse MJ
    Eur Heart J; 1992 Nov; 13 Suppl F():30-7. PubMed ID: 1335870
    [No Abstract]   [Full Text] [Related]  

  • 8. [Present status in and prospects for anti-arrhythmic drug therapy: Theoretical selection of therapeutic drugs for arrhythmia by Sicilian Gambit and the practice guidelines].
    Kato T
    Nihon Naika Gakkai Zasshi; 2006 Feb; 95(2):246-52. PubMed ID: 16536074
    [No Abstract]   [Full Text] [Related]  

  • 9. Concept of the vulnerable parameter: the Sicilian Gambit revisited.
    Rosen MR; Janse MJ
    J Cardiovasc Pharmacol; 2010 May; 55(5):428-37. PubMed ID: 19755918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Sicilian Gambit and antiarrhythmic drug development.
    Colatsky TJ
    Cardiovasc Res; 1992 Jun; 26(6):562-5. PubMed ID: 1333361
    [No Abstract]   [Full Text] [Related]  

  • 11. Update on antiarrhythmic drug pharmacology.
    Huang CL; Wu L; Jeevaratnam K; Lei M
    J Cardiovasc Electrophysiol; 2020 Feb; 31(2):579-592. PubMed ID: 31930579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiarrhythmic drug classifications and the clinician: a gambit in the land of chaos.
    Katritsis D; Camm AJ
    Clin Cardiol; 1994 Mar; 17(3):142-8. PubMed ID: 7513270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The search for novel antiarrhythmic strategies. Sicilian Gambit.
    Eur Heart J; 1998 Aug; 19(8):1178-96. PubMed ID: 9740340
    [No Abstract]   [Full Text] [Related]  

  • 14. [Selection of anti-arrhythmia agents--application of the Sicilian Gambit].
    Ogawa S
    Nihon Naika Gakkai Zasshi; 1999 Mar; 88(3):432-5. PubMed ID: 10341618
    [No Abstract]   [Full Text] [Related]  

  • 15. ["Sicilian gambit": basic principles and strategies of anti-arrhythmia therapy. Satellite symposium of the 15th Congress of the European Society for Cardiology, Barcelona, 30 August 1992].
    Internist (Berl); 1993 Jan; 34(1 Suppl [sizilian]):1-20. PubMed ID: 8626211
    [No Abstract]   [Full Text] [Related]  

  • 16. [Sicilian gambit; a new strategy for antiarrhythmic therapy].
    Katoh T
    J Nippon Med Sch; 2002 Feb; 69(1):7-12. PubMed ID: 11847503
    [No Abstract]   [Full Text] [Related]  

  • 17. The Sicilian Gambit: a response to Drs Colatsky and Harrison.
    Rosen MR; Janse MJ; Schwartz PJ
    Cardiovasc Res; 1992 Jun; 26(6):568-70. PubMed ID: 1451135
    [No Abstract]   [Full Text] [Related]  

  • 18. [Current classification of anti-arrhythmia agents].
    Weirich J; Wenzel W
    Z Kardiol; 2000; 89 Suppl 3():62-7. PubMed ID: 10810787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of recent ion channel science on the development and use of antiarrhythmic drugs.
    Langan MN
    Curr Cardiol Rep; 1999 Nov; 1(4):302-7. PubMed ID: 10980858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of arrhythmias: enhanced automaticity and reentry.
    Weller DM; Noone J
    Crit Care Nurse; 1989 May; 9(5):42-67. PubMed ID: 2680278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.